Nei pazienti che venivano dalla tirzepatide, orforglipron ha mantenuto il 74,7% del peso perso contro il 49,2% del placebo
Theyll also need to provider patient education around payer eligibility criteria and potentially offer alternative therapies for patients unwilling or unable to take on higher treatment costs
In this case, we contacted the authors group for further information, and tried to include the study as much as possible
However, patients should always follow their prescriber's guidance for Ozempic titration according to the product information, as dosing should be adjusted based on glycaemic control and tolerability, not to control weight loss rate
E-EL-R3007, Elabscience, Texas, USA), TGF-1 (Cat no
By reducing food intake and exercising more, you lose weight